echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Huawei enters the medical device market with a registration certificate to compete for a piece of the medical field

    Huawei enters the medical device market with a registration certificate to compete for a piece of the medical field

    • Last Update: 2021-08-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Huawei has obtained the registration certificate through the Guangdong Province registrant pilot, and it has become a reality to enter the medical device field
    .
    Regarding the entry of the medical device market, the Daily Economic News reported that Huawei responded that Huawei will make equipment connected to medical equipment.


    On this basis, it may provide health and medical assistance solutions to the market with partners in the future


    Development, production and sales of medical equipment

    Development, production and sales of medical equipment

    A few days ago, the Guangdong Provincial Food and Drug Administration officially announced the "List of Products Approved for the Pilot Program of Medical Device Registrant System in Guangdong Province" (as of August 2, 2021).
    : wrist single-lead ECG acquisition, as trustee for the Beijing Weifang Hi-Tech electronic Technology Co.
    , Ltd
    .

    According to the company's information, Huawei Terminal Co.
    , Ltd.
    belongs to Huawei, with a registered capital of RMB 60 million.
    The date of establishment is November 23, 2012.
    The number of employees is more than 10,000.
    From the perspective of its business scope, it includes development and production.
    , Sales: medical devices (Class 1, Class 2, and Class 3 medical devices), and provide technical consultation and after-sales service; value-added telecommunications business operations; commission agency; import and export of goods or technology (the state prohibits or involves administrative approval Except for the import and export of goods and technology)
    .

    In May of this year, “He Gang”, president of Huawei’s consumer business mobile phone product line, posted on Weibo that Huawei’s first smartwatch that can measure blood pressure has passed the medical device registration test.
    The next step will be to start a registered clinical trial with professional medical institutions.
    It will be officially listed in half a year
    .

    He Gang said that Huawei has continued to cultivate in the health field and is committed to bringing more professional health services to everyone
    .
    Earlier, He Gang revealed at the pollen annual meeting that Huawei is developing wearable blood pressure measurement equipment and will start research on hypertension management with well-known domestic institutions to explore innovative active health management of blood pressure from screening to early intervention


    .


    Huawei has also broken through the continuous body temperature detection technology based on smart wear, and is conducting joint research on smart body temperature to achieve abnormal body temperature screening
    .
    Huawei is conducting joint research on intelligent screening and early warning of coronary heart disease.


    With the help of Huawei's smart watch ECG collection capabilities, it integrates PPG and ACC data to achieve intelligent screening and early warning of coronary heart disease to help consumers proactively manage their health


    ECG monitoring is the first point?

    ECG monitoring is the first point?

    In February of this year, according to the company's investigation, Huawei Technologies Co.
    , Ltd.
    's patent information on "apparatus and method for electrocardiogram measurement" was authorized to be published, the patent publication number is CN108601544B
    .
    The embodiments of the invention relate to the technical field of medical devices, and more specifically, to devices and methods for electrocardiogram measurement


    .


    This patent was applied for on July 29, 2016
    .
    The patent describes a method of using multiple potential sensors to capture electrical signals, and then signal processing through signal amplifiers, analog-to-digital converters, filters, etc.


    , to obtain effective ECG signals


    According to the observation of Cyber ​​Blue, the applicant for this patent is: Huawei Technologies Co.
    , Ltd.
    ; the address of the applicant is the office building of Huawei headquarters in Bantian, Longgang District, Shenzhen, Guangdong Province
    .

    Huawei also disclosed an electrocardiogram detection device on November 24, 2020.
    The application provides an electrocardiogram detection device to reduce the difficulty of design and manufacture of the electrocardiogram detection device
    .

    It is reported that the ECG detection device includes a wearable body and an ECG detection module.
    Among them, the ECG detection module is detachably connected to the wearable body.
    The ECG detection module includes a housing, a substrate, an ECG acquisition circuit, and internal and external electrodes.
    , The substrate is arranged in the housing, the ECG acquisition circuit is arranged on the substrate, the inner electrode and the outer electrode are arranged on the outer wall of the housing, and the inner electrode is arranged on the side close to the substrate and electrically connected with the ECG acquisition circuit, and the outer electrode is close to the substrate The other side is set and electrically connected with the ECG acquisition circuit
    .

    Huawei disclosed a robot and ECG detection method in September 2020
    .
    Solve the problem of inconvenience in operation when the existing portable ECG recorder is used for ECG detection


    .


    Competing for a share in the medical field

    Competing for a share in the medical field

    As a representative of domestic technology companies, Huawei has always been in the medical field
    .

    According to Huawei's official display, Huawei has launched: Huawei Atlas intelligent evaluation solution for new coronary pneumonia, Atlas artificial intelligence computing platform, combined with medical PACS equipment, so that it has edge AI computing capabilities, can achieve real-time multi-color rendering of lesions, and automatic pneumonia grading , Intuitive comparison of the baseline histogram, the efficiency of evaluating patients with pneumonia is increased by more than 9 times compared with the traditional scheme
    .

    On April 1, 2020, Honor Terminal Co.
    , Ltd.
    invested by Huawei was established with a registered capital of 300 million yuan
    .
    The company is wholly-owned by Huawei Investment Holdings Co.


    , Ltd.


    At the end of November 2019, the business of Deep Thinking Artificial Intelligence Robot Technology (Beijing) Co.
    , Ltd.
    invested by Hubble Technology Investment Co.
    , Ltd.
    , a wholly-owned subsidiary of Huawei, changed its business, selling medical devices Class I and II, computers, software, and copying equipment
    .

    At the end of March 2019, Huawei changed the company's business scope and added medical device sales and other businesses
    .
    Huawei Terminal Co.


    , Ltd.


    In response to the incoming medical device market, according to the Daily Business News report, Huawei responded that Huawei will make equipment connected to medical equipment; on this basis, it may provide health and medical assistance solutions to the market with partners in the future
    .

    According to Huawei's official website observed by Cyber ​​Blue Devices: Huawei Medical has currently served more than 3,000 medical and health service organizations
    .
    To provide the medical industry with comprehensive coverage, safe and controllable, simple operation and maintenance, and future-oriented wireless network solutions
    .

    According to the Artery Network report, in the construction case of the First Affiliated Hospital of Zhengda University, the person in charge of Huawei Wireless XLabs once said that Huawei and operators have worked together to provide customers with 5G solutions
    .
    It is reported that the first remote 5G animal surgery and human surgery were completed by Huawei in cooperation with China Unicom and China Mobile
    .

    At the same time, Huawei has made progress in many directions during the exploration process of Xlabs, a wireless application scenario laboratory, including more than 280 partners in the industry chain such as operators, hospitals, and medical equipment manufacturers, and more than 40 cooperations have been formed.
    Research project
    .

    In terms of informatization construction, Huawei has also served a large number of tertiary hospitals
    .

    Co-built a big data integration and application platform with West China Hospital, and planned and designed the top-level design and implementation of the digital hospital in the new district of West China Second Hospital together with customers
    .
    Establish a security protection system with Tongren Hospital; use micro-module solutions to help the People's Liberation Army General Hospital, Nanjing Gulou and other hospitals build highly integrated and easy-to-maintain data centers
    .

    Cyberlane will continue to pay attention to what Huawei will do in the future
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.